Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Wright Reports
Provider: Reuters Investment Profile
Provider: Thomson Reuters Stock Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Orient Bio Inc Announces Amendments to Rights Issue

Thursday, 14 Mar 2013 04:38am EDT 

Orient Bio Inc announced that it has made amendments to the previously announced rights issue of 20 million common shares. After the amendments, the shareholders will have rights to purchase new rights shares from May 8, 2013 to May 9, 2013 and the listing date of the new shares will be May 31, 2013. KRW 5,971,517,533 of the proceeds will be used for its facilities, KRW 1,743,482,467 will be used for its operations and KRW 2,285 million will be used as other funds. 

Company Quote

1.0 +0.13%
19 Dec 2014